Latest Share Chat

VRP.L Share News (VRP)

VRP.L Information

There is currently no data for VRP

Verona Pharma's loss widens on extended development costs

Tue, 12th May 2015 16:22

Verona Pharma posted a widened pre-tax loss for 2014 in the run up to its lead compound's commercial development.The company posted a pre-tax loss of £3.8m for 2014, up from £2.8m a year earlier, as research costs swelled from £1.7m to £2.6m over the period.Development bore a new commercial formulation of RPL554, which is currently in phas1/11 clinical trials. The next installment of the study in chronic obstructive pulmonary disease patients is expected to report later in 2015, though data also suggests the drug has potential to treat cystic fibrosis.The company does not currently produce revenue, but it raised £14m in a share placing in March, which will go towards the development of RPL553 for severe chronic obstructive pulmonary disease, as well as covering administrative expenses."We remain confident that with multiple potential applications, each representing an attractive commercial opportunity, RPL554 has the potential to generate significant value for shareholders," said Chief Executive Officer Jan-Anders Karlsson in a statement.Shares in Verona were trading down 1.48% at 3.33p late Tuesday afternoon.

More News

12 Jan 2015 11:55

Verona Pharma doses first volunteers in 'RPL554' asthma trial

Verona Pharma said the first group of volunteers have been dosed with its new nebulised formulation of its RPL554 product as part of a Phase I/II clinical trial, which analysts said was a significant step. The AIM company said the study's main objective was to confirm the safety, tolerability and br

12 Jan 2015 09:23

Verona Pharma Doses First Recruitments In RPL554 Clinical Trial

30 Sep 2014 12:38

CORRECT: UK WINNERS & LOSERS: Intertek's Gain Is Inchcape's Loss On CEO Change

30 Sep 2014 12:35

UK MIDDAY BRIEFING: Clothing Retailers Hit By Next Weather Warning

30 Sep 2014 11:51

UK WINNERS & LOSERS: Intertek's Gain Is Inchcape's Loss On CEO Change

30 Sep 2014 09:07

Verona Pharma Appoints Biresh Roy As Chief Financial Officer

29 Sep 2014 07:45

Verona Shares Up As Data Shows Potential Of RPL554 In Cystic Fibrosis

11 Sep 2014 11:01

Verona Pharma Posts Widened Loss As It Continues Drug Development

23 Jun 2014 10:47

UK MIDDAY BRIEFING: ASOS Hit By Suspicious Warehouse Fire

23 Jun 2014 10:10

UK WINNERS & LOSERS: Mining Companies Cheered By China PMI Data

23 Jun 2014 07:27

UK MORNING BRIEFING: Shares Down As Iraq Fighting Lifts Oil Prices

23 Jun 2014 06:47

Verona Pharma To Halt VRP700 Development After Trial Failure

28 Apr 2014 08:53

Verona Pharma Loss Widens As It Continues To Develop Pipeline Drugs

LONDON (Alliance News) - Verona Pharma PLC Monday posted a widened pretax loss for 2013 as it continued to develop its two pipeline drugs towards commercialisation. Veron posted a pretax loss of GBP2.8 million, widened from a pretax loss of GBP2.6 million in 2012, as administration expense

7 Mar 2014 12:51

UK MIDDAY BRIEFING: Boohoo.com Latest On IPO Catwalk

LONDON (Alliance News) - Online fashion retailer Boohoo.com, the latest UK retailer to firm up its initial public offering, has said it plans to raise GBP300 million in the AIM listing, giving it a higher-then-expected initial market capitalisation of GBP560 million.

Read more

7 Mar 2014 10:57

UK WINNERS & LOSERS: Aviva Leads Blue-Chip Risers Again

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Friday. ------- FTSE 100 - WINNERS Aviva, up 4.2%. After closing as the blue-chip index's biggest riser on Thursday, Aviva is again the stand out performer Frid

Latest Share Chat

VRP.L Share News (VRP)

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Verona Pharma's loss widens on extended development costs

Login to your account

Quickpicks are a member only feature

Login to your account